Kidney transplant outcomes in patients with complement dysregulation

Table 1 Baseline demographic and clinical characteristics of the study cohort, n (%)

Variable	Value
Age (years)
mean ± SD	36.3 ± 9.3
Median (IQR)	33.0 (30.3-43.8)
Range	22-58
Sex
Male	32 (84.2)
Female	6 (15.8)
Hypertension
Present	37 (97.4)
Absent	1 (2.6)
Diabetes status
Diabetes mellitus	1 (2.6)
Post-transplant diabetes mellitus (NODAT)	3 (7.9)
No diabetes	34 (89.5)
Clinical scenario at diagnosis of complement abnormality
CKD stage V on maintenance hemodialysis	28 (73.7)
Advanced CKD stage V not on dialysis	3 (7.9)
AKI	3 (7.9)
Diagnosed post-transplant	4 (10.5)
Median post-transplant follow-up (months)	12
Survival at last follow-up
Alive	36 (94.7)
Deceased	2 (5.3)

AKI: Acute kidney injury; CKD: Chronic kidney disease; IQR: Interquartile range; NODAT: New-onset diabetes after transplantation; SD: Standard deviation.